Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy
about
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseInflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.Phosphorylated α-synuclein in Parkinson's disease.Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directionsVersatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasisLow levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment.Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans.Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's diseasePioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.CSF complement 3 and factor H are staging biomarkers in Alzheimer's diseaseBiomarkers of basic activities of daily living in Alzheimer's disease.Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ.What does complement do in Alzheimer's disease? Old molecules with new insights.Cerebrospinal fluid biomarkers in Parkinson disease.Innate immunity and neuroinflammation.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.The role of complement in neurological and neuropsychiatric diseases.Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes.CCAAT/enhancer binding protein β directly regulates the expression of the complement component 3 gene in neural cells: implications for the pro-inflammatory effects of this transcription factor.Let's make microglia great again in neurodegenerative disorders.Potential clinical utility of multiple system atrophy biomarkers.Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress.Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease
P2860
Q26849232-28EEC47C-1271-4731-AF04-6A4C422DC9CFQ27022728-25D39017-91E8-4EA5-A608-94D7D92DE116Q27311994-00C7A6FF-EBF4-4411-A88E-262651EC967BQ30510167-56A95031-73A2-4C39-8959-4B5509A81D22Q33769278-E4D77660-F558-4A94-B4BA-41D2335D8D97Q34237637-B0C989D3-5C8D-4D56-8F90-8022DD2D974DQ34471200-781E233D-4E90-4BF0-8D95-A6AEFCCDFCBDQ34630522-330A753F-612F-4740-A645-4A855280A001Q34804797-42C6C141-8559-4C19-9FDF-280156142AB4Q35250966-25E32517-B56E-4FE3-A68F-C9E83BA791F6Q35542811-76FD1587-6365-4F76-9767-0F43074D52D2Q36152393-934E825E-A15C-4893-A200-47294DFCFE4BQ36219387-5CD28C33-CD95-473A-87A5-1FF197B1BA3FQ36337525-A8F084D8-DA88-4EB1-901F-F2568C273C8CQ36410286-B98EE34B-B54B-4564-ADBD-21F4217625EBQ36456719-CC4FF89E-CCCF-488A-9331-09911466174FQ36592268-B63B2E50-A83A-4BDE-A6E1-1FD37BD6742BQ36818214-EAFBDA97-30C2-424F-B904-825B70AAC814Q36998284-03159294-3311-426A-9F98-29A54F102935Q37356880-625FC5CE-8B0C-4538-8B2F-D762B4B9D1ADQ37368120-A03D035B-F793-4241-8392-270AC3256A00Q38082586-A674827E-70B9-47D6-8F40-BCB22851C2CCQ38120744-5D66A496-96A2-4EEA-8D0A-051CBB1003B1Q38271572-49C5D29D-D307-4746-84A0-6E88FD26AFF7Q38590250-DFD23934-D161-4A3D-9C67-8B08A82A5A99Q38761739-29B04AEE-117C-4125-BE3F-9E971AEA1901Q38887260-93011980-7818-476C-BCF1-CDFD175A7BF0Q38916940-2559E2DE-7C29-4C76-A49B-87341BEAFE5BQ46926746-05CA6803-7791-4C36-AB7F-D8581A7B1AC5Q47663712-B2B6BE8F-48C9-401A-87C5-682C540DF8F7Q48184416-9242E2AE-CA2E-4A2A-9A73-3B3465D063ABQ49651549-78C4354B-15B3-4FD3-91C4-812C9CE83D47Q57675765-AA311FB9-2F78-482A-BB16-9E5E3D229146
P2860
Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@ast
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@en
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@nl
type
label
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@ast
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@en
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@nl
prefLabel
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@ast
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@en
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@nl
P2093
P2860
P50
P921
P1476
Complement 3 and factor h in h ...... e, and multiple-system atrophy
@en
P2093
Aneeka M Hancock
Carmen Ginghina
David S Goldstein
Douglas Galasko
Elaine R Peskind
Hojoong M Kim
Jing Zhang
Joseph Jankovic
Joshua Bradner
Karen L Edwards
P2860
P304
P356
10.1016/J.AJPATH.2011.01.006
P407
P577
2011-04-01T00:00:00Z